Source: NatPharm gears for local production of pharmaceuticals – herald Sunday Mail Reporter THE Government plans to ...
New long-term clinical data for Blueprint Medicines' drug Ayvakit (avapritinib) were presented at the ASH congress in Orlando, reinforcing the treatment's pr ...
Patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancers had similar progression-free survival (PFS) whether they were treated with sacituzumab govitecan-hziy (Trodelvy) or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback